FDA Adverse Event Death Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1891217 · Received October 29, 2010

Report

Report Number
2024168-2010-02284
Event Type
Death
Date Received
October 29, 2010
Date of Event
May 16, 2010
Report Date
October 6, 2010
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OK, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). STENT THROMBOSIS IS A KNOWN ADVERSE EVENTS AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE.

Additional Manufacturer Narrative · 1

(B)(4). THERE WAS NO REPORTED PRODUCT DEFICIENCY. DEATH IS A KNOWN ADVERSE EVENT AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECT AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 1

SUBSEQUENT TO THE INITIAL MEDWATCH REPORT, THE FOLLOWING INFORMATION AS RECEIVED: THE DEATH WAS POSSIBLY CAUSED BY LATE STENT THROMBOSIS.

Description of Event or Problem · 1

IT WAS REPORTED VIA TRIAL THAT APPROX 6 MONTHS POST DIRECT XIENCE V STENT IMPLANTATION IN THE DISTAL CIRCUMFLEX (DCX) AND THE DISTAL RIGHT CORONARY ARTERY (DRCA), THE PT DIED AT HOME IN BED. REPORTEDLY, PER THE PHYSICIAN, THE DEATH WAS NOT RELATED TO THE DEVICE OR THE PROCEDURE. THE FAMILY HAS NOT PROVIDED ADD'L DETAILS. ALTHOUGH REQUESTED, THERE WAS NO ADD'L INFO PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT NA 9021241

Patients

Seq Age Sex Outcome Treatment
1 71 YR Death STENT: XIENCE V STENT 1009542-08 LOT 9011261| SERIAL (B)(4) (DISTAL CX)